SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2.
SGLT2 抑制剂恩格列净通过下调肾小管 PKM2 来改善 DKD 中的肾小管间质纤维化
期刊:Cellular and Molecular Life Sciences
影响因子:6.2
doi:10.1007/s00018-025-05688-8
Cai Xiang, Cao Huanyi, Wang Meijun, Yu Piaojian, Liang Xiaoqi, Liang Hua, Xu Fen, Cai Mengyin
